n-methyl-1-(1,3-benzodioxol-5-yl)-2-butanamine has been researched along with Amphetamine-Related Disorders in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Corkery, J; Deluca, P; Ghodse, AH; Oyefeso, A; Schifano, F | 1 |
1 other study(ies) available for n-methyl-1-(1,3-benzodioxol-5-yl)-2-butanamine and Amphetamine-Related Disorders
Article | Year |
---|---|
Ecstasy (MDMA, MDA, MDEA, MBDB) consumption, seizures, related offences, prices, dosage levels and deaths in the UK (1994-2003).
Topics: 3,4-Methylenedioxyamphetamine; Amphetamine-Related Disorders; Cause of Death; Crime; Cross-Sectional Studies; Dose-Response Relationship, Drug; Drug and Narcotic Control; Humans; Illicit Drugs; N-Methyl-3,4-methylenedioxyamphetamine; Statistics as Topic; United Kingdom | 2006 |